Please use this identifier to cite or link to this item:
|Title:||Efficacy of high-dose palliative radiotherapy for localised, castration-resistant prostate cancer.|
|Epworth Authors:||Bowden, Patrick|
|Other Authors:||White, Rohen|
Tai, Keen Hun
|Keywords:||Radiation Oncology, Epworth Healthcare, Melbourne, VIC, Australia|
High-Dose Palliative Radiotherapy
Castration-Resistant Prostate Cancer
|Publisher:||Science Direct / Elsevier|
|Citation:||Clin Oncol (R Coll Radiol). 2015 Jan;27(1):16-21.|
|Abstract:||AIMS: There are limited outcome data after radiotherapy treatment for clinically localised, castration-resistant prostate cancer. We report our single institution experience on patient outcomes in this group using high-dose palliative radiotherapy (HDPRT). MATERIALS AND METHODS: A retrospective review of patient hospital records was conducted in prostate cancer patients treated with palliative intent radiotherapy and restricted to those who had castration-resistant disease, no evidence of regional or distant disease and who received a local radiotherapy dose equivalent to 40 Gy or greater.|
|Journal Title:||Clinical Oncology (The Royal College of Radiologists)|
|Affiliated Organisations:||Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.|
Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
Department of Biochemistry, Monash University, Melbourne, VIC, Australia
Department of Medical Radiations, Monash University, Melbourne, VIC, Australia
|Type of Clinical Study or Trial:||Retrospective Reviews|
|Appears in Collections:||Cancer Services|
Files in This Item:
There are no files associated with this item.
Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.